MFG
DGX icon

Merit Financial Group’s Quest Diagnostics DGX Stock Holding History

Merit Financial Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
6,006
+69
+1% +$13.5K 0.01% 962
2026
Q1 		$1.16M Sell
5,937
-632
-10% -$123K 0.01% 912
2025
Q4 		$1.14M Buy
6,569
+685
+12% +$125K 0.01% 886
2025
Q3 		$1.12M Buy
5,884
+1,801
+44% +$320K 0.01% 807
2025
Q2 		$733K Buy
4,083
+522
+15% +$90.7K 0.01% 924
2025
Q1 		$603K Buy
3,561
+1,109
+45% +$182K 0.01% 852
2024
Q4 		$370K Buy
2,452
+696
+40% +$108K 0.01% 839
2024
Q3 		$273K Sell
1,756
-304
-15% -$45.4K 0.01% 697
2024
Q2 		$282K Sell
2,060
-4,346
-68% -$595K 0.01% 751
2024
Q1 		$880K Sell
6,406
-425
-6% -$55.1K 0.02% 439
2023
Q4 		$942K Buy
6,831
+386
+6% +$50.7K 0.03% 331
2023
Q3 		$785K Buy
6,445
+176
+3% +$23.4K 0.03% 367
2023
Q2 		$881K Buy
6,269
+89
+1% +$12.3K 0.03% 359
2023
Q1 		$874K Buy
6,180
+77
+1% +$11K 0.03% 305
2022
Q4 		$955K Buy
+6,103
New +$877K 0.03% 306

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Merit Financial Group's DGX Position: Q2 2026 in Review

Merit Financial Group increased its Quest Diagnostics (DGX) stake by 1.2% in Q2 2026, buying an estimated $13.5K and bringing the position to 6,006 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #962.

Merit Financial Group first reported a position in DGX in Q4 2022 and has held it in 15 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Merit Financial Group held 6,006 shares of Quest Diagnostics worth $1.27M as of Q2 2026.
  • Merit Financial Group bought 69 Quest Diagnostics shares in Q2 2026, an estimated $13.5K.
  • Quest Diagnostics made up 0.01% of Merit Financial Group's portfolio in Q2 2026, its #962 holding.
  • Merit Financial Group first reported a position in Quest Diagnostics in Q4 2022 and has held it in 15 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.